- Home
- AURE vs COYA Comparison
AURE vs COYA Comparison
Compare AURE & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AURE | COYA |
|---|---|---|
| Founded | 2018 | 2020 |
| Country | Hong Kong | United States |
| Employees | 4 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.9M | 97.8M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | AURE | COYA |
|---|---|---|
| Price | $2.30 | $5.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $15.80 |
| AVG Volume (30 Days) | 30.4K | ★ 128.7K |
| Earning Date | 06-01-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,945,753.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $763.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 123.57 |
| 52 Week Low | $0.18 | $3.71 |
| 52 Week High | $3.53 | $7.75 |
Technical Indicators
Market Signals| Indicator | AURE | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 49.18 | 58.35 |
| Support Level | $2.33 | $4.45 |
| Resistance Level | $2.59 | $5.18 |
| Average True Range (ATR) | 0.12 | 0.36 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 31.71 | 74.73 |
Price Performance
Historical ComparisonAbout AURE Prestige Wealth Inc. Class A Ordinary Shares
Aurelion Inc is a Tether Gold (XAUT) Real World Asset (RWA) company focused on developing a business around tokenized gold. XAUT combines the stability of physical gold with the efficiency of blockchain, providing investors access to a tokenized gold reserve that could serve as a haven to inflation, currency devaluation, and crypto volatility. In parallel to building a business around the development of tokenized gold, Aurelion provides wealth management and asset management services.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.